OPKO HEALTH, INC. 8-K

What Happened

• On February 26, 2026, OPKO Health, Inc. announced operating and financial highlights for the quarter and year ended December 31, 2025, via a press release (attached as Exhibit 99.1). The release also provides details for a conference call where management will discuss fourth-quarter and full-year 2025 results, business updates, and financial guidance. The 8-K was signed by Adam Logal, SVP and Chief Financial Officer.

Key Details

• Date of release/filing: February 26, 2026.
• Period covered: Quarter and fiscal year ended December 31, 2025.
• Materials: Press release attached as Exhibit 99.1 (information furnished, not filed under Section 18).
• Purpose: Announce quarterly and annual operating/financial highlights and provide conference call access and guidance information.

Why It Matters

• This 8-K signals OPKO is publicly releasing its Q4 and full-year 2025 earnings-related information and forward-looking guidance, which can affect earnings expectations and the stock price. The scheduled conference call gives investors direct access to management commentary on revenue, results, and strategy. Note the press release is furnished (not “filed”), which limits certain legal liabilities and incorporation by reference into other filings.